Uroexam spol. s r.o.
- Address
- lock Available on a paid plan
Oncology and Urologic Cancer Research
At Uroexam spol. s r.o. in Nitra, the clinical trial portfolio is centered on prostate cancer and related neoplasms, with a strong focus on how to better control disease spread and recurrence.
- Studying oligometastatic prostate cancer and metastatic castration-resistant prostate cancer
- Evaluating new approaches for metastasis-free survival and disease recurrence
- Assessing whether novel treatments can improve outcomes compared with observation or existing care
The research here aims to test new therapies and refine treatment strategies for men with advanced or high-risk prostate cancer, helping determine which options may offer better disease control and longer-lasting benefit.
Hormone-Sensitive Prostate Cancer Studies
This site is also involved in trials for metastatic hormone-sensitive prostate cancer and other advanced forms of the disease, with attention to treatment effectiveness in patients whose tumors show specific biological features.
- Investigating PTEN-deficient metastatic hormone-sensitive prostate cancer
- Comparing combination treatment strategies with standard hormone-based therapy
- Exploring ways to improve control of radiographic progression
The main purpose of these studies is to evaluate whether adding new targeted or hormone-based treatments can improve outcomes for patients with aggressive prostate cancer while maintaining acceptable safety.
Advanced Therapy and Long-Term Safety
Several trials at the urology outpatient clinic focus on advanced treatment options and follow-up care, including studies designed to understand the longer-term effects of therapies already helping patients.
- Reviewing long-term safety in patients benefiting from enzalutamide
- Assessing new hormone-related treatment options for advanced prostate cancer
- Supporting treatment decisions for men with persistent or recurrent disease
These studies are intended to better define how established and emerging treatments perform over time, with an emphasis on safety, continued benefit, and improved management of urologic malignancies.
Imaging-Guided and Radiation-Based Research
The site contributes to trials that combine radiotherapy, hormone therapy, and advanced imaging to study how treatment can delay progression in patients with high-risk or nonmetastatic prostate cancer.
- Using PSMA-PET to track disease behavior and treatment response
- Evaluating whether adding therapy to radiotherapy improves outcomes
- Measuring delays in metastatic progression and disease recurrence
These investigations are aimed at improving both diagnostics and treatment planning, helping clinicians identify disease earlier and choose therapies that may better control spread.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uroexam spol. s r.o.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Enzalutamide and Leuprorelin Acetate in High-Risk Nonmetastatic Prostate Cancer Post-Definitive Therapy | Medivation Inc. | Phase III | Not Recruiting | Aug 2015 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Enzalutamide | 3 | Unknown | 2015-08-19 | 2026-03-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.